Actionable news
All posts from Actionable news
Actionable news in ACAD: ACADIA Pharmaceuticals Inc.,

Acadia's New Drug Offers Big Upside for Investors

A Hillary Clinton Sept. 21 tweet sent the biotech sector into a tailspin. The Presidential candidate said that she would take on those companies that sold overpriced drugs. Clinton's comments resonated with many observers of biotech and big pharma who have repeatedly questioned the business model of drug companies.

In the aftermath, biotech and some pharmaceutical stocks suffered. Many have yet to recover.

One such company is Acadia Pharmaceuticals (ACAD - Get Report) . Acadia is a biopharmaceutical company that focuses on the development and commercialization of small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. But the company offers an excellent investment opportunity, largely because of a potential blockbuster drug that will help sufferers of Parkinson's disease. Acadia's financial...